We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
26.50 | 1.98% | 1,368.00 | 1,370.00 | 1,370.50 | 1,372.00 | 1,341.00 | 1,341.00 | 7,976,847 | 16:35:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.52 | 55.61B |
Date | Subject | Author | Discuss |
---|---|---|---|
16/8/2022 19:05 | The plaintiff in the first Zantac case appears to have voluntarily dismissed the case without settlement according to news wires | daneswooddynamo | |
16/8/2022 12:51 | You wouldn't need a penny for halfpenny's thoughts......we all get them for free.How lucky are we? | redbaron10 | |
16/8/2022 11:35 | So you are not worth even a penny! | abdullla | |
16/8/2022 11:32 | just filter him.. | lippy4 | |
16/8/2022 11:29 | Change the record pal | alibizzle | |
16/8/2022 11:07 | GSK are a very high risk. Its only greed that keeps many holding onto GSK. Its therefore important that many are aware of the Risks and avoid the hype its a good investment at this time of many Cancer Claims. So dont fall into any traps as MM’s will sell before you do. Q. Do you feel lucky??? | halfpenny | |
16/8/2022 10:45 | Halfpenny I'm not sure what you have against GSK and the joy you are taking from seeing investors lose money , but please stop as you are t helping anyone and it's pretty pathetic tbf | alibizzle | |
16/8/2022 10:24 | halfpenny16 Aug '22 - 11:19 - 30609 of 30609 (filtered) | tradermichael | |
16/8/2022 10:24 | court case story has run out of steam. People are vaguely beginning to think in terms of recovery back to 1500, 1700 and 2200 | netcurtains | |
16/8/2022 10:19 | GSK don't be fooled as plenty of falls in the pipeline as Claims increase. Too Risky at this level the risk reward is low. Lawyers are ramping up claimants and getting ready for their Xmas bonuses. I see this as a small Cat bounce or is it a Kitten Bounce with huge falls to come soon. 800 or less is very feasible at this Risky stage.. | halfpenny | |
16/8/2022 09:22 | fair play one and all. luck to you as well. | unastubbs | |
16/8/2022 09:05 | I need £17 to break even but tbh happy to sit on a loss for 2-3 years and collect dividends if need be | alibizzle | |
16/8/2022 09:04 | About 2200 for me. Not sure. Who cares? Break even is not a thing, I always say it is where you are now that counts, not the past - that is been and gone. GSK appears to be going up. And that is good! | netcurtains | |
16/8/2022 08:50 | High £15's for me right now. A few days of gains north of 20p and I may top up / average down. That would give me confidence that £14 is the low. | tuftymatt | |
16/8/2022 08:43 | what's your break even btw? | unastubbs | |
16/8/2022 08:40 | dont be late | netcurtains | |
16/8/2022 08:30 | woke appointment. gwgb. | unastubbs | |
16/8/2022 08:11 | Substitute Walmsley full stop. | tradermichael | |
16/8/2022 07:39 | Good to see GSK bounce back today. I am a bit worried about the Elliott position (among other things!!). News in the FT today that Elliott has exited its $2.5en investment in SoftBank after losing faith that the CEO could turn it around. The shares were acquired in 2020, Elliott are thought to have sold some in 2021 at a good profit and then unloaded the rest earlier this year as the share price fell back. Substitute GSK for SoftBank and Walmsley for Maysayoshi Son and the story could be otherwise identical. | spyder | |
16/8/2022 07:13 | From todays announcement: " Tony Wood, Chief Scientific Officer, GSK , said: "Affinivax's exciting pneumococcal vaccine candidates, the potentially disruptive MAPs technology and their fantastic scientific talent, further strengthen our pipeline of novel vaccines and presence in the Boston area". " | netcurtains | |
16/8/2022 07:06 | Let's start as we mean to go on 👍🏻 | tuftymatt | |
16/8/2022 00:17 | free stock charts from uk.advfn.com | buywell3 | |
15/8/2022 21:06 | No professional company would release confidential information. So looks like it is just fake | maxplus2 | |
15/8/2022 21:03 | It is written last year. Irrelevant | maxplus2 | |
15/8/2022 20:13 | What is clear is that GSK have a hell of a lot to offer. Expect that we are at a price that could make us vulnerable | hamid1970 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions